Literature DB >> 29052161

Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.

Roberta Ara1, Tessa Peasgood2, Clara Mukuria2, Helene Chevrou-Severac3, Donna Rowen2, Ismail Azzabi-Zouraq3, Suzy Paisley2, Tracey Young2, Ben van Hout2, John Brazier2.   

Abstract

Mesh：

Year:  2017        PMID： 29052161     DOI： 10.1007/s40273-017-0543-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  15 in total

1.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Authors:  Milton C Weinstein; Bernie O'Brien; John Hornberger; Joseph Jackson; Magnus Johannesson; Chris McCabe; Bryan R Luce
Journal:  Value Health       Date:  2003 Jan-Feb       Impact factor: 5.725

2.  Variational methods for fitting complex Bayesian mixed effects models to health data.

Authors:  Cathy Yuen Yi Lee; Matt P Wand
Journal:  Stat Med       Date:  2015-09-28       Impact factor: 2.373

3.  A taxonomy of model structures for economic evaluation of health technologies.

Authors:  Alan Brennan; Stephen E Chick; Ruth Davies
Journal:  Health Econ       Date:  2006-12       Impact factor: 3.046

4.  Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.

Authors:  Eva Kaltenthaler; Paul Tappenden; Suzy Paisley
Journal:  Value Health       Date:  2013-06-19       Impact factor: 5.725

5.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

6.  Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.

Authors:  Sorrel E Wolowacz; Andrew Briggs; Vasily Belozeroff; Philip Clarke; Lynda Doward; Ron Goeree; Andrew Lloyd; Richard Norman
Journal:  Value Health       Date:  2016 Sep - Oct       Impact factor: 5.725

7.  Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.

Authors:  Allan J Wailoo; Monica Hernandez-Alava; Andrea Manca; Aurelio Mejia; Joshua Ray; Bruce Crawford; Marc Botteman; Jan Busschbach
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

8.  Estimating mean total costs in the presence of censoring: a comparative assessment of methods.

Authors:  Tracey A Young
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

10.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Cost Eff Resour Alloc       Date:  2013-03-25
View more
  2 in total

1.  Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT).

Authors:  Michael J Zoratti; Kelvin K W Chan; Don Husereau; Murray Krahn; Mitchell Levine; Lehana Thabane; Feng Xie
Journal:  Pharmacoeconomics       Date:  2021-06-21       Impact factor: 4.981

2.  Heath State Utility Values for Cost-Effectiveness Models.

Authors:  Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.